Mesa Labs in $180m Gyros acquisition for biopharma asset development
Mesa Labs buys Gyros to gain access to the latter’s capabilities in the discovery, development and manufacture of biotherapeutics.
Archives for November 12, 2019
Panthera kicks off with first clinical site, looks to fully virtualize trials
Panthera opens a clinical trials site, the first of a number planned, which will enable virtualization of visits, and ‘potentially entire trials’.
Mallinckrodt looks to grow CMO business to offset opioid headwind
Mallinckrodt talks up prospect of contract manufacturing growth offsetting opioid headwind faced by its speciality generics business.